(Q34723522)

4 August 2017

title

Effect of nifedipine on exercise tolerance in patients with angina pectoris. (English)

1 reference

4 August 2017

1 reference

J H Atterhög

1

1 reference

4 August 2017

L G Ekelund

series ordinal

2

1 reference

4 August 2017

A L Melin

series ordinal

3

1 reference

4 August 2017

publication date

1 February 1975

1 reference

European Journal of Clinical Pharmacology

4 August 2017

published in

1 reference

4 August 2017

volume

8

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

125-130

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00561561

4 August 2017

exact match

0 references

cites work

Perceived exertion as an indicator of somatic stress

1 reference

12 December 2020

Effect of Nifedipine (BAY a 1040) on work electrocardiogram of angina pectoris patients

1 reference

12 December 2020

[Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++

1 reference

12 December 2020

The indicative value of central hemodynamic changes following the administration of an o-nitrophenyl-dihydropyridine derivative

1 reference

12 December 2020

CIRCULATORY STUDIES ON HEALTHY OLD MEN. WITH SPECIAL REFERENCE TO THE LIMITATION OF THE MAXIMAL PHYSICAL WORKING CAPACITY

1 reference

12 December 2020

[BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium]

1 reference

12 December 2020

Cardiohemodynamic effects of BAY a 1040 in the dog

1 reference

12 December 2020

Hemodynamic and therapeutic effect of BAY a 1040 on the patients with ischemic heart disease

1 reference

12 December 2020

Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)

1 reference

12 December 2020

The effect of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid methyl ester on myocardial metabolism, hemodynamics, blood gases and general metabolism of man

1 reference

12 December 2020

Effect of BAY a 1040 on renal function in hypertension

1 reference

12 December 2020

The clinical effect of 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine (BAY a 1040) on angina pectoris evaluated by sequential analysis

1 reference

12 December 2020

Changed hemodynamics of the left heart under the influence of Nifedipine (BAY a 1040) as compared to nitroglycerin

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00561561

1 reference

Dimensions Publication ID

4 August 2017

1050414476

0 references

1 reference